Table 6.
DSCAM-AS1 | Controls | 0.48* | 0.0001 | |||||||||
Patients | 0.66* | <0.0001 | ||||||||||
SPRY4-IT | Controls | 0.45* | 0.0004 | 0.63* | <0.0001 | |||||||
Patients | 0.51* | 0.0001 | 0.49* | 0.0003 | ||||||||
LINC-ROR | Controls | 0.31 | 0.0167 | 0.63* | <0.0001 | 0.57* | <0.0001 | |||||
Patients | 0.53* | <0.0001 | 0.45 | 0.001 | 0.55* | <0.0001 | ||||||
MEG3 | Controls | 0.33* | 0.0096 | 0.60* | <0.0001 | 0.42* | 0.0008 | 0.61* | <0.0001 | |||
Patients | 0.46* | 0.0006 | 0.35 | 0.0123 | 0.25 | 0.0738 | 0.49* | 0.0003 | ||||
PVT1 | Controls | 0.46* | 0.0003 | 0.43* | 0.0006 | 0.36 | 0.0051 | 0.47* | 0.0002 | 0.44* | 0.0006 | |
Patients | 0.34 | 0.0138 | 0.40 | 0.0035 | 0.32 | 0.0207 | 0.58* | <0.0001 | 0.55* | <0.0001 | ||
R | P Value | R | P Value | R | P Value | R | P Value | R | P Value | |||
HULC | DSCAM-AS1 | SPRY4-IT | LINC-ROR | MEG3 |
Correlations between expressions of lncRNAs in study groups (R values are presented; after correction for multiple comparisons (Bonferroni correction), P value less than 0.0016 was accepted as significant.
* shows significance.